Intel Corporation's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 27, 2025 · FY), Intel Corporation reported revenue of $52.9B (-0.5% year on year) and net income of ($267.0M) (+98.6% year on year).
| Line item | Dec 27, 2025 · FY | Dec 28, 2024 · FY | Dec 30, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net revenue | $52.9B | $53.1B | $54.2B | $63.1B |
| Cost of sales | $34.5B | $35.8B | $32.5B | $36.2B |
| Gross profit | $18.4B | $17.3B | $21.7B | $26.9B |
| Research and development | $13.8B | $16.5B | $16.0B | $17.5B |
| Marketing, general, and administrative | $4.6B | $5.5B | $5.6B | $7.0B |
| Restructuring and other charges | $2.2B | $7.0B | ($62.0M) | $2.0M |
| Operating expenses | $20.6B | $29.0B | $21.6B | $24.5B |
| Operating income (loss) | ($2.2B) | ($11.7B) | $93.0M | $2.3B |
| Gains (losses) on equity investments, net | $514.0M | $242.0M | $40.0M | $4.3B |
| Interest and other, net | $3.3B | $226.0M | $629.0M | $1.2B |
| Income (loss) before taxes | $1.6B | ($11.2B) | $762.0M | $7.8B |
| Provision for (benefit from) taxes | $1.5B | $8.0B | ($913.0M) | ($249.0M) |
| Net income (loss) | $26.0M | ($19.2B) | $1.7B | $8.0B |
| Less: net income (loss) attributable to non-controlling interests | $293.0M | ($477.0M) | ($14.0M) | $3.0M |
| Net income (loss) attributable to Intel | ($267.0M) | ($18.8B) | $1.7B | $8.0B |
| Earnings (loss) per share attributable to Intel—basic (in dollars per share) | -$0.06 | -$4.38 | $0.40 | $1.95 |
| Earnings (loss) per share attributable to Intel—diluted (in dollars per share) | -$0.06 | -$4.38 | $0.40 | $1.94 |
| Basic (shares) | 4.5B | 4.3B | 4.2B | 4.1B |
| Diluted (shares) | 4.5B | 4.3B | 4.2B | 4.1B |
| Line item | Jun 27, 2026 · Q2 | Mar 28, 2026 · Q1 | Sep 27, 2025 · Q3 | Jun 28, 2025 · Q2 |
|---|---|---|---|---|
| Net revenue | $16.1B | $13.6B | $13.7B | $12.9B |
| Cost of sales | $9.6B | $8.2B | $8.4B | $9.3B |
| Gross profit | $6.5B | $5.3B | $5.2B | $3.5B |
| Research and development | $3.4B | $3.4B | $3.2B | $3.7B |
| Marketing, general, and administrative | $1.2B | $1.0B | $1.1B | $1.1B |
| Restructuring and other charges | $170.0M | $4.1B | $175.0M | $1.9B |
| Operating expenses | $4.7B | $8.5B | $4.5B | $6.7B |
| Operating income (loss) | $1.8B | ($3.1B) | $683.0M | ($3.2B) |
| Gains (losses) on equity investments, net | ($39.0M) | ($72.0M) | $221.0M | $502.0M |
| Interest and other, net | ($12.6B) | ($738.0M) | $3.7B | ($95.0M) |
| Income (loss) before taxes | ($10.8B) | ($3.9B) | $4.6B | ($2.8B) |
| Provision for (benefit from) taxes | $29.0M | $335.0M | $304.0M | $255.0M |
| Net income (loss) | ($10.8B) | ($4.3B) | $4.3B | ($3.0B) |
| Less: net income (loss) attributable to non-controlling interests | $185.0M | ($553.0M) | $207.0M | ($106.0M) |
| Net income (loss) attributable to Intel | ($11.0B) | ($3.7B) | $4.1B | ($2.9B) |
| Earnings (loss) per share attributable to Intel—basic (in dollars per share) | -$2.16 | -$0.73 | $0.90 | -$0.67 |
| Earnings (loss) per share attributable to Intel—diluted (in dollars per share) | -$2.16 | -$0.73 | $0.90 | -$0.67 |
| Weighted average shares of common stock outstanding—basic (in shares) | 5.1B | 5.1B | 4.5B | 4.4B |
| Weighted average shares of common stock outstanding—diluted (in shares) | 5.1B | 5.1B | 4.5B | 4.4B |
| Line item | Dec 27, 2025 · FY | Dec 28, 2024 · FY | Dec 30, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $14.3B | — | — | — |
| Short-term investments | $23.2B | $13.8B | $18.0B | $17.2B |
| Accounts receivable, net | $3.8B | $3.5B | $3.4B | $4.1B |
| Inventories | $11.6B | $12.2B | $11.1B | $13.2B |
| Other current assets | $10.8B | $9.6B | $3.7B | $4.7B |
| Total current assets | $63.7B | $47.3B | $43.3B | $50.4B |
| Property, plant and equipment, net | $105.4B | $107.9B | $96.6B | $80.9B |
| Equity investments | $8.5B | $5.4B | $5.8B | $5.9B |
| Goodwill | $23.9B | $24.7B | $27.6B | $27.6B |
| Identified intangible assets, net | $2.8B | $3.7B | $4.6B | $6.0B |
| Other long-term assets | $7.1B | $7.5B | $13.6B | $11.3B |
| Total assets | $211.4B | $196.5B | $191.6B | $182.1B |
| Short-term debt | $2.5B | $3.7B | $2.3B | $4.4B |
| Accounts payable | $9.9B | $12.6B | $8.6B | $9.6B |
| Accrued compensation and benefits | $4.0B | $3.3B | $3.7B | $4.1B |
| Income taxes payable | $604.0M | $1.8B | $1.1B | $2.3B |
| Other accrued liabilities | $14.6B | $14.3B | $12.4B | $11.9B |
| Total current liabilities | $31.6B | $35.7B | $28.1B | $32.2B |
| Debt | $44.1B | $46.3B | $47.0B | $37.7B |
| Other long-term liabilities | $9.4B | $9.5B | $6.6B | $5.0B |
| Preferred stock, $0.001 par value, 50 shares authorized; none issued | 0 | 0 | 0 | 0 |
| Common stock, $0.001 par value, 10,000 shares authorized; 4,994 shares issued and outstanding (4,330 issued and outstanding in 2024) and capital in excess of par value | 65.2B | 50.9B | 36.6B | 31.6B |
| Accumulated other comprehensive income (loss) | $113.0M | ($711.0M) | ($215.0M) | ($562.0M) |
| Retained earnings | $49.0B | $49.0B | $69.2B | $70.4B |
| Total Intel stockholders' equity | $114.3B | $99.3B | $105.6B | $101.4B |
| Non-controlling interests | $12.1B | $5.8B | $4.4B | $1.9B |
| Total stockholders' equity | $126.4B | $105.0B | $110.0B | $103.3B |
| Total liabilities and stockholders' equity | $211.4B | $196.5B | $191.6B | $182.1B |
| Line item | Jun 27, 2026 | Mar 28, 2026 | Sep 27, 2025 | Jun 28, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $12.9B | $17.2B | $11.1B | $9.6B |
| Short-term investments | $16.9B | $15.5B | $19.8B | $11.6B |
| Accounts receivable, net | $4.0B | $4.1B | $3.2B | $2.4B |
| Inventories | $12.5B | $12.4B | $11.5B | $11.4B |
| Other current assets | $11.0B | $12.9B | $6.1B | $8.4B |
| Total current assets | $57.2B | $62.2B | $51.7B | $43.4B |
| Property, plant, and equipment, net of accumulated depreciation of $109,918 ($106,464 as of December 27, 2025) | $105.7B | $104.5B | $105.0B | $109.5B |
| Equity investments | $8.4B | $8.5B | $8.7B | $5.4B |
| Goodwill | $20.5B | $20.5B | $23.9B | $23.9B |
| Identified intangible assets, net | $2.5B | $2.7B | $2.9B | $3.1B |
| Other long-term assets | $8.1B | $7.0B | $12.3B | $7.3B |
| Total assets | $202.4B | $205.3B | $204.5B | $192.5B |
| Accounts payable | $8.8B | $7.2B | $10.3B | $10.7B |
| Accrued compensation and benefits | $3.7B | $2.8B | $3.8B | $4.2B |
| Short-term debt | $2.0B | $2.0B | $2.5B | $6.7B |
| Other accrued liabilities | $21.2B | $14.9B | $15.0B | $12.4B |
| Total current liabilities | $35.7B | $26.9B | $32.3B | $35.0B |
| Debt | $48.5B | $43.0B | $44.1B | $44.0B |
| Other long-term liabilities | $15.1B | $10.4B | $11.4B | $7.8B |
| Common stock and capital in excess of par value, 5,043 issued and outstanding (4,994 issued and outstanding as of December 27, 2025) | $53.8B | $66.3B | $56.8B | $52.3B |
| Accumulated other comprehensive income (loss) | ($80.0M) | ($44.0M) | $19.0M | $65.0M |
| Retained earnings | $33.8B | $45.2B | $49.6B | $45.5B |
| Total Intel stockholders' equity | $87.5B | $111.4B | $106.4B | $97.9B |
| Non-controlling interests | $15.6B | $13.6B | $10.4B | $7.9B |
| Total stockholders' equity | $103.1B | $125.0B | $116.7B | $105.8B |
| Total liabilities and stockholders’ equity | $202.4B | $205.3B | $204.5B | $192.5B |
| Line item | Dec 27, 2025 · FY | Dec 28, 2024 · FY | Dec 30, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents, beginning of period | $8.2B | $7.1B | $11.1B | $4.8B |
| Net income (loss) | $26.0M | ($19.2B) | $1.7B | $8.0B |
| Depreciation | $10.8B | $10.0B | $7.8B | $11.1B |
| Share-based compensation | $2.4B | $3.4B | $3.2B | $3.1B |
| Restructuring and other charges | $476.0M | $3.5B | ($424.0M) | $1.1B |
| Amortization of intangibles | $949.0M | $1.4B | $1.8B | $1.9B |
| (Gains) losses on equity investments, net | ($514.0M) | ($246.0M) | ($42.0M) | ($4.3B) |
| Mark-to-market (gains) losses on Escrowed Shares | 1.8B | — | — | — |
| (Gains) losses on divestitures | ($5.3B) | $0 | $0 | ($1.1B) |
| Deferred taxes | $328.0M | $6.1B | — | — |
| Impairments and net (gain) loss on retirement of property, plant and equipment | $515.0M | $2.3B | — | — |
| Accounts receivable | ($449.0M) | ($75.0M) | $731.0M | $5.3B |
| Inventories | ($138.0M) | ($1.1B) | $2.1B | ($2.4B) |
| Accounts payable | $297.0M | $634.0M | ($801.0M) | ($29.0M) |
| Accrued compensation and benefits | $788.0M | ($218.0M) | ($614.0M) | ($1.5B) |
| Income taxes | ($995.0M) | ($356.0M) | ($3.5B) | ($4.5B) |
| Other assets and liabilities | ($1.3B) | $2.2B | ($451.0M) | ($1.3B) |
| Total adjustments | $9.7B | $27.5B | $9.8B | $7.4B |
| Net cash provided by (used for) operating activities | $9.7B | $8.3B | $11.5B | $15.4B |
| Additions to property, plant and equipment | ($14.6B) | ($23.9B) | ($25.8B) | ($24.8B) |
| Proceeds from capital-related government incentives | $1.6B | $1.9B | $1.0B | — |
| Purchases of short-term investments | ($24.3B) | ($37.9B) | ($44.4B) | ($43.6B) |
| Maturities and sales of short-term investments | $15.4B | $41.5B | $44.1B | $48.7B |
| Sales of equity investments | $671.0M | $1.0B | $472.0M | $5.0B |
| Proceeds from Divestiture of Businesses | $6.2B | $0 | $0 | $6.6B |
| Other investing | $352.0M | ($736.0M) | $962.0M | ($1.5B) |
| Net cash provided by (used for) investing activities | ($14.8B) | ($18.3B) | ($24.0B) | ($10.5B) |
| Issuance of commercial paper, net of issuance costs | $3.5B | $7.3B | $0 | $3.9B |
| Repayment of commercial paper | ($3.5B) | ($7.3B) | ($3.9B) | — |
| Partner contributions | $5.1B | $12.7B | $1.5B | $874.0M |
| Net proceeds from sales of subsidiary shares | 921.0M | 0 | 3.0B | 1.0B |
| Additions to property, plant and equipment | ($3.0B) | ($1.2B) | — | — |
| Issuance of long-term debt, net of issuance costs | $0 | $3.0B | $11.4B | $6.5B |
| Repayment of debt | ($3.8B) | ($2.3B) | ($423.0M) | ($5.0B) |
| Proceeds from sales of common stock through employee equity incentive plans | $771.0M | $987.0M | $1.0B | $977.0M |
| Net proceeds attributed to common stock and warrants issued, and Escrowed Shares | 12.7B | — | — | — |
| Restricted stock unit withholdings | ($423.0M) | ($631.0M) | — | — |
| Payment of dividends to stockholders | $0 | ($1.6B) | ($3.1B) | ($6.0B) |
| Other financing | ($720.0M) | $158.0M | ($847.0M) | ($689.0M) |
| Net cash provided by (used for) financing activities | $11.6B | $11.1B | $8.5B | $1.4B |
| Net increase (decrease) in cash and cash equivalents | $6.5B | $1.2B | ($4.1B) | $6.3B |
| Cash, cash equivalents, and restricted cash, end of period | $14.7B | — | — | — |
| Acquisition of property, plant and equipment | $5.0B | $8.1B | $4.8B | $5.4B |
| Interest, net of capitalized interest | $1.1B | $987.0M | $613.0M | $459.0M |
| Line item | Jun 27, 2026 · YTD | Mar 28, 2026 · Q1 | Sep 27, 2025 · YTD | Jun 28, 2025 · YTD |
|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash, beginning of period | $14.7B | $14.7B | $8.2B | $8.2B |
| Net income (loss) | ($15.1B) | ($4.3B) | $359.0M | ($3.9B) |
| Depreciation | $5.9B | $2.9B | $8.0B | $5.2B |
| Share-based compensation | $1.3B | $621.0M | $1.9B | $1.3B |
| Restructuring and other charges | $4.0B | $4.0B | $372.0M | $382.0M |
| Amortization of intangibles | $469.0M | $234.0M | $708.0M | $474.0M |
| (Gains) losses on equity investments, net | $111.0M | $72.0M | ($611.0M) | ($390.0M) |
| Mark-to-market (gains) losses on Escrowed Shares | 13.6B | 1.1B | 1.7B | — |
| Deferred taxes | ($27.0M) | ($9.0M) | $123.0M | $106.0M |
| Impairments and net (gain) loss on retirement of property, plant, and equipment | $165.0M | — | $465.0M | $482.0M |
| Accounts receivable | ($221.0M) | ($217.0M) | $162.0M | $1.0B |
| Inventories | ($874.0M) | ($808.0M) | ($9.0M) | $99.0M |
| Accounts payable | $310.0M | ($142.0M) | ($281.0M) | $114.0M |
| Accrued compensation and benefits | ($372.0M) | ($1.2B) | $541.0M | $1.0B |
| Income taxes | ($477.0M) | $169.0M | ($1.2B) | ($1.3B) |
| Other assets and liabilities | ($637.0M) | ($1.3B) | ($1.4B) | ($1.7B) |
| Total adjustments | $23.2B | $5.4B | $5.0B | $6.8B |
| Net cash provided by (used for) operating activities | $8.1B | $1.1B | $5.4B | $2.9B |
| Additions to property, plant, and equipment | ($6.2B) | ($3.6B) | ($11.2B) | ($8.7B) |
| Proceeds from capital-related government incentives | $167.0M | $107.0M | $1.0B | $964.0M |
| Acquisitions, net of cash acquired | ($596.0M) | ($596.0M) | — | — |
| Purchases of short-term investments | ($12.7B) | ($7.2B) | ($16.4B) | ($5.7B) |
| Sales of short-term investments | $11.0B | $9.2B | — | — |
| Maturities of short-term investments | $7.7B | $5.2B | $11.0B | $8.6B |
| Proceeds from divestitures, net | $0 | $0 | $6.2B | $1.9B |
| Other investing | ($44.0M) | ($40.0M) | $494.0M | $984.0M |
| Net cash provided by (used for) investing activities | ($669.0M) | $3.1B | ($8.3B) | ($2.0B) |
| Issuance of commercial paper, net of issuance costs | $0 | $0 | $3.5B | $3.5B |
| Repayment of commercial paper | $0 | — | ($3.5B) | ($1.5B) |
| Payments on finance leases | ($832.0M) | — | — | — |
| Partner contributions | $4.1B | $2.1B | $3.7B | $2.2B |
| Partner distributions | ($14.3B) | — | — | — |
| Additions to property, plant, and equipment | ($1.4B) | ($1.3B) | ($2.5B) | ($2.0B) |
| Issuance of term debt, net of issuance costs | $13.0B | — | $0 | $0 |
| Repayment of term debt | ($9.0B) | ($1.5B) | ($3.8B) | ($1.5B) |
| Proceeds from sales of common stock through employee equity incentive plans | $427.0M | $427.0M | $777.0M | $491.0M |
| Restricted stock unit withholdings | ($617.0M) | — | — | — |
| Other financing | $154.0M | ($870.0M) | ($1.1B) | ($678.0M) |
| Net cash provided by (used for) financing activities | ($8.5B) | ($1.2B) | $5.7B | $586.0M |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | ($1.1B) | $3.0B | $2.9B | $1.4B |
| Cash, cash equivalents, and restricted cash, end of period | $13.6B | — | — | — |
| Acquisition of property, plant, and equipment | $3.1B | $1.9B | $5.1B | $5.2B |
| Recognition of capital-related government incentives | $632.0M | $639.0M | $6.1B | $1.5B |
| Interest, net of capitalized interest | $531.0M | $600.0M | $1.2B | $514.0M |
| Income taxes, net of refunds | $904.0M | $261.0M | $1.9B | $1.8B |
Intel Corporation score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.